Emami (NSE:EMAMILTD, BOM:531162) has an average rating of buy and mean price target of 605.86 Indian rupees, according to analysts polled by FactSet.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
Suzlon Energy (NSE:SUZLON, BOM:532667) has received a repeat order of 195 MW from Sunsure Energy for the latter's project in the Bijapur district of Karnataka, India, according to a Friday filing to the Indian stock exchanges.The latest order, the cumulative partnership between Suzlon and Sunsure, has increased to nearly 300 MW across the states of Maharashtra and Karnataka.Under the latest contract, Suzlon will install 65 units of S144 wind turbine generators (WTGs), each rated at a 3.0 MW capacity. The renewable energy company will supply wind turbines, execute the project, including erection and commissioning, along with operations and maintenance services post-commissioning.With this order, the company's order book in Karnataka now stands at over 2 GW.The company's shares were up over 1% in recent trade.
Shanghai Shyndec Pharmaceutical (SHA:600420) received a drug registration certificate from China's National Medical Products Administration for ibrutinib capsules, according to a Shanghai bourse filing on Friday.The drug is used to treat cancers such as lymphoma and Waldenström Macroglobulinemia.The pharmaceutical company invested 15.6 million yuan into the drug's research and development.